Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain

Joint Bone Spine

Volumn 70, Issue 5, 2003, Pages 356-361

  Tüzün, Fikret ^a   Ünalan, Halil ^a,f   Öner, Nazan ^b   Özgüzel, Hayri ^b   Kirazli, Yeşim ^c   Içaǧasioǧlu, Afitap ^d   Kuran, Banu ^e   Tüzün, Şansin ^a   Başar, Günnur ^g  

^a ISTANBUL UNIVERSITY   (Turkey)

^b OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c EGE UNIVERSITY   (Turkey)

^d SSK Goztepe Hospital   (Turkey)

^e SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f Catalcesme Hatboyu sok   (Turkey)

^g NONE

Author keywords

Low back pain; Muscle relaxant; Thiocolchicoside

Indexed keywords

COLCHICINE; DRUG DERIVATIVE; MUSCLE RELAXANT AGENT; PARACETAMOL; PLACEBO; THIOCOLCHICOSIDE;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEARTBURN; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE SPASM; NAUSEA; PAIN ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 10744228198     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(03)00075-7     Document Type: Article

References (13)

1. Torstensen TA, Ljunggren AE, Meen HD, Odland E, Mowinckel P, Geijerstam S. Efficiency and costs of medical exercise therapy, conventional physiotherapy and self exercise in patients with chronic low back pain: a pragmatic, randomized, single-blinded, controlled trial with 1 year follow-up. Spine 1998;23:2616-24.
2. Borenstein DG. Epidemiology, etiology, diagnostic evaluation and treatment of low back pain. Curr Opin Rheumatol 2001; 13:128-34.
3. Frank JW, Brooker AS, DeMaio SE, et al. Disability resulting from occupational low back pain: part II. What do we know about secondary prevention? A review of the scientific evidence on prevention after disability begins. Spine 1996;21:2018-27.
4. Frank JW, Kerr MS, Brooker AS, et al. Disability resulting from occupational low back pain: part I. What do we really know about primary prevention? A review of the scientific evidence on prevention before disability begins. Spine 1996;21:2008-17.
5. Frymoyer JW, Durett CL. The economics of spinal disorders. 2nd ed. In: Frymoyer JW, editor. The adult spine: principles and practice. Philadelphia: Lippincott-Raven; 1997, p. 143-50.
6. Van Tulder MW, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine 1997;22:2128-56.
7. Marcel C, Rezvani Y, Revel M. Evaluation du thiocolchicoside en monotherapie dans le lumbago douloureux: Resultats d'une étude randomisée contre placebo. Presse Méd 1990; 19:1133-6.
8. Pietrogrande V, Cherubino P, Peretti G, Manzini E, Letizia G. Studio policentrico, randomizzato, doppio cieco: MuscoRil capsule e fiale vs. Placebo in patologie ortopedico-traumatologiche. Ort Traum Oggi 1992;12:132-7.
9. Runyon RP, Haber A, Fundamentals of behavioral statistics, 4th ed. California: Addison-Wesley Publishing Company; 1980.
10. Casale R. Acute low back pain. Symptomatic treatment with a muscle relaxant. Drug Clin J Pain 1988;4:81-8.
11. Lipetz JS, Mlanga GA. Oral medications in the treatment of acute low back pain. Occup Med:State Art Rev 1998; 13:151-66.
12. Van Tulder MW, Scholton RJPM, Koost WB, Deyo RA. Nonsteroidal anti-inflammatory drugs for low back pain. Spine 2000;2:2501-13.
13. Patat A, Klein MJ, Surjus A, Renault M, Rezvani Y, Granier J, Effects of acute and repeated doses of two muscles relaxants chlormezasone and thiocolchicoside, on vigilance and psychomotor performance of healty volunteers. Hum Psychopharmacol 1991;6:285-92.